These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

959 related items for PubMed ID: 36558421

  • 21. Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children.
    Stepanov YM, Zavhorodnia NY, Yagmur VB, Lukianenko OY, Zygalo EV.
    Wiad Lek; 2019; 72(3):350-356. PubMed ID: 31050979
    [Abstract] [Full Text] [Related]

  • 22. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
    Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J, Yong JN, Zeng RW, Chew NWS, Nah B, Kulkarni A, Siddiqui MS, Dan YY, Wong VW, Sanyal AJ, Noureddin M, Muthiah M, Ng CH.
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis.
    Losurdo G, Marra A, Shahini E, Girardi B, Giorgio F, Amoruso A, Pisani A, Piscitelli D, Barone M, Principi M, Di Leo A, Ierardi E.
    Neurogastroenterol Motil; 2017 Jun; 29(6):. PubMed ID: 28191721
    [Abstract] [Full Text] [Related]

  • 26. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
    Ebadi M, Ip S, Bhanji RA, Montano-Loza AJ.
    Nutrients; 2021 Aug 30; 13(9):. PubMed ID: 34578919
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis.
    Kalligeros M, Vassilopoulos A, Shehadeh F, Vassilopoulos S, Lazaridou I, Mylonakis E, Promrat K, Wands JR.
    Clin Gastroenterol Hepatol; 2023 Jul 30; 21(7):1708-1722. PubMed ID: 36642292
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T, Goto T, Hirotsu Y, Masuzaki R, Moriyama M, Omata M.
    Int J Mol Sci; 2020 Feb 23; 21(4):. PubMed ID: 32102237
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
    Rich NE, Oji S, Mufti AR, Browning JD, Parikh ND, Odewole M, Mayo H, Singal AG.
    Clin Gastroenterol Hepatol; 2018 Feb 23; 16(2):198-210.e2. PubMed ID: 28970148
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    Su T, Lai S, Lee A, He X, Chen S.
    J Gastroenterol; 2018 Jan 23; 53(1):27-36. PubMed ID: 28770351
    [Abstract] [Full Text] [Related]

  • 39. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
    Younossi Z, Aggarwal P, Shrestha I, Fernandes J, Johansen P, Augusto M, Nair S.
    JHEP Rep; 2022 Sep 23; 4(9):100525. PubMed ID: 36039144
    [Abstract] [Full Text] [Related]

  • 40. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.
    Ferolla SM, Armiliato GN, Couto CA, Ferrari TC.
    Nutrients; 2014 Dec 03; 6(12):5583-99. PubMed ID: 25479248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.